Phenominer Database Results (28 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
SD body weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 77.0 days 6 403.2 g 7.4 18.13 body weighing method 0.0 lad occlusion 28 days 101075 2564
SD body weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 189.0 days 10 568.3 g 34.1 107.83 body weighing method 0.0 lad occlusion 140 days 101077 2564
SD systolic blood pressure left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. arterial blood pressure trait male 189.0 days 10 undefined 143.0 mmHg 3.0 9.49 tail cuff plethysmography 0.0 lad occlusion 140 days 101089 2564
SD heart right ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77.0 days 6 0.62 mg/g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101103 2564
SD heart right ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189.0 days 10 0.52 mg/g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days 101105 2564
SD heart right atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77.0 days 6 0.11 mg/g 0.0 0.01 ex vivo method 0.0 lad occlusion 28 days raw/bw 101119 2564
SD heart septum weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 189.0 days 10 0.33 g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days septum 101125 2564
SD heart weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77.0 days 6 1.25 g 0.02 0.05 ex vivo method 0.0 lad occlusion 28 days 101079 2564
SD heart left ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189.0 days 10 1.53 mg/g 0.04 0.13 ex vivo method 0.0 lad occlusion 140 days 101097 2564
SD right atrium weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77.0 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 lad occlusion 28 days 101115 2564
SD heart weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189.0 days 10 1.57 g 0.06 0.19 ex vivo method 0.0 lad occlusion 140 days 101081 2564
SD heart weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77.0 days 6 3.09 g/kg 0.03 0.07 ex vivo method 0.0 lad occlusion 28 days 101083 2564
SD heart left ventricle weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189.0 days 10 0.87 g 0.03 0.09 ex vivo method 0.0 lad occlusion 140 days 101093 2564
SD heart right ventricle weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77.0 days 6 0.25 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101099 2564
SD left atrium weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77.0 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 lad occlusion 28 days 101107 2564
SD right atrium weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189.0 days 10 0.05 g 0.0 0.01 ex vivo method 0.0 lad occlusion 140 days 101117 2564
SD heart right atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189.0 days 10 0.09 mg/g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days raw/bw 101121 2564
SD heart septum weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 77.0 days 6 0.24 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days septum 101123 2564
SD heart left ventricle infarction area to total heart left ventricle area ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle integrity trait male 77.0 days 6 35.4 % 1.9 4.65 ex vivo visual assessment 0.0 lad occlusion 28 days 101127 2564
SD systolic blood pressure left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. arterial blood pressure trait male 77.0 days 6 undefined 125.0 mmHg 3.0 7.35 tail cuff plethysmography 0.0 lad occlusion 28 days 101087 2564
SD left atrium weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189.0 days 10 0.05 g 0.0 0.01 ex vivo method 0.0 lad occlusion 140 days 101109 2564
SD heart left atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77.0 days 6 0.1 mg/g 0.0 0.01 ex vivo method 0.0 lad occlusion 28 days law/bw 101111 2564
SD heart left ventricle infarction area to total heart left ventricle area ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle integrity trait male 189.0 days 10 37.9 % 2.0 6.32 ex vivo visual assessment 0.0 lad occlusion 140 days 101128 2564
SD heart weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189.0 days 10 2.78 g/kg 0.07 0.22 ex vivo method 0.0 lad occlusion 140 days 101085 2564
SD heart left ventricle weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77.0 days 6 0.67 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101091 2564
SD heart left ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77.0 days 6 1.67 mg/g 0.04 0.1 ex vivo method 0.0 lad occlusion 28 days 101095 2564
SD heart right ventricle weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189.0 days 10 0.29 g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days 101101 2564
SD heart left atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189.0 days 10 0.08 mg/g 0.01 0.02 ex vivo method 0.0 lad occlusion 140 days law/bw 101113 2564